147 related articles for article (PubMed ID: 8655143)
1. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis.
Tokino T; Urano T; Furuhata T; Matsushima M; Miyatsu T; Sasaki S; Nakamura Y
Hum Genet; 1996 May; 97(5):625-31. PubMed ID: 8655143
[TBL] [Abstract][Full Text] [Related]
2. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.
Matsuoka S; Thompson JS; Edwards MC; Bartletta JM; Grundy P; Kalikin LM; Harper JW; Elledge SJ; Feinberg AP
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3026-30. PubMed ID: 8610162
[TBL] [Abstract][Full Text] [Related]
3. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
Lee MH; Reynisdóttir I; Massagué J
Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
[TBL] [Abstract][Full Text] [Related]
4. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
5. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.
Hatada I; Mukai T
Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351
[TBL] [Abstract][Full Text] [Related]
6. Human metalloprotease/disintegrin-like (MDC) gene: exon-intron organization and alternative splicing.
Katagiri T; Harada Y; Emi M; Nakamura Y
Cytogenet Cell Genet; 1995; 68(1-2):39-44. PubMed ID: 7956356
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas.
Ferrando AA; Balbín M; Pendás AM; Vizoso F; Velasco G; López-Otín C
Hum Genet; 1996 Jan; 97(1):91-4. PubMed ID: 8557269
[TBL] [Abstract][Full Text] [Related]
8. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay.
Reid LH; Crider-Miller SJ; West A; Lee MH; Massagué J; Weissman BE
Cancer Res; 1996 Mar; 56(6):1214-8. PubMed ID: 8640800
[TBL] [Abstract][Full Text] [Related]
9. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.
Shin JY; Kim HS; Lee KS; Kim J; Park JB; Won MH; Chae SW; Choi YH; Choi KC; Park YE; Lee JY
Exp Mol Med; 2000 Jun; 32(2):79-83. PubMed ID: 10926119
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.
Orlow I; Iavarone A; Crider-Miller SJ; Bonilla F; Latres E; Lee MH; Gerald WL; Massagué J; Weissman BE; Cordón-Cardó C
Cancer Res; 1996 Mar; 56(6):1219-21. PubMed ID: 8640801
[TBL] [Abstract][Full Text] [Related]
11. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.
Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK
Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
[TBL] [Abstract][Full Text] [Related]
14. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
15. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.
Blais A; Labrie Y; Pouliot F; Lachance Y; Labrie C
Biochem Biophys Res Commun; 1998 Jun; 247(1):146-53. PubMed ID: 9636670
[TBL] [Abstract][Full Text] [Related]
16. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.
Kondo M; Matsuoka S; Uchida K; Osada H; Nagatake M; Takagi K; Harper JW; Takahashi T; Elledge SJ; Takahashi T
Oncogene; 1996 Mar; 12(6):1365-8. PubMed ID: 8649840
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.
Watanabe H; Pan ZQ; Schreiber-Agus N; DePinho RA; Hurwitz J; Xiong Y
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1392-7. PubMed ID: 9465025
[TBL] [Abstract][Full Text] [Related]
18. Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Vazquez MP; Gicquel C
Horm Res; 2000; 54(1):1-5. PubMed ID: 11182628
[TBL] [Abstract][Full Text] [Related]
19. P57 (KIP2) polymorphisms and breast cancer risk.
Li Y; Millikan RC; Newman B; Conway K; Tse CK; Liu ET
Hum Genet; 1999 Jan; 104(1):83-8. PubMed ID: 10071197
[TBL] [Abstract][Full Text] [Related]
20. Mutational study of p16CDKN2/MTS1/INK4A and p57KIP2 genes in hepatocellular carcinoma.
Bonilla F; Orlow I; Cordón-Cardó C
Int J Oncol; 1998 Mar; 12(3):583-8. PubMed ID: 9472096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
